AChE-IN-7
IC50 AChE 0.045 +/- 0.005 microM; BChE 19.68 +/- 0.02 microM; Inhibition of Abeta aggregation 35.3 +/- 0.05 % at 25microM
General
Type : Oxoisoaporphine, Alkaloid
Chemical_Nomenclature : 11-[4-(2-methylpiperidin-1-yl)butoxy]-16-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one
Canonical SMILES : CC1CCCCN1CCCCOC2=CC3=C4C(=C2)C=CN=C4C5=CC=CC=C5C3=O
InChI : InChI=1S\/C26H28N2O2\/c1-18-8-4-5-13-28(18)14-6-7-15-30-20-16-19-11-12-27-25-21-9-2-3-10-22(21)26(29)23(17-20)24(19)25\/h2-3,9-12,16-18H,4-8,13-15H2,1H35-[2-(2-methylpiperidine -1-amino) propoxyl]-1-azabenzanthrone
InChIKey : HVLZKNWEYCJMJK-UHFFFAOYSA-N
Other name(s) : CHEMBL5202300 || BDBM50593613 || HY-144660 || Compound 16
MW : 400.5
Formula : C26H28N2O2
CAS_number : 2699090-78-1
PubChem : 163196412
UniChem : HVLZKNWEYCJMJK-UHFFFAOYSA-N
Target
Families : AChE-IN-7 ligand of proteins in family
ACHE
Protein :
human-ACHE
References (1)
| Title : Development of 5-hydroxyl-1-azabenzanthrone derivatives as dual binding site and selective acetylcholinesterase inhibitors - Sun_2022_Eur.J.Med.Chem_234_114210 |
| Author(s) : Sun X , Wang Y , Lei Z , Yue S , Chen L , Sun J |
| Ref : Eur Journal of Medicinal Chemistry , 234 :114210 , 2022 |
| Abstract : |
| PubMedSearch : Sun_2022_Eur.J.Med.Chem_234_114210 |
| PubMedID: 35303485 |